Overview Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation Status: Completed Trial end date: 2015-05-01 Target enrollment: Participant gender: Summary Safety and Tolerability Extension Trial for Patients with Chronic Idiopathic Constipation (CIC) Phase: Phase 3 Details Lead Sponsor: Ferring Pharmaceuticals